Christopher Parsons

820 total citations
23 papers, 466 citations indexed

About

Christopher Parsons is a scholar working on Oncology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher Parsons has authored 23 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher Parsons's work include Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and HIV Research and Treatment (3 papers). Christopher Parsons is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and HIV Research and Treatment (3 papers). Christopher Parsons collaborates with scholars based in United States, Poland and United Kingdom. Christopher Parsons's co-authors include Dean H. Kedes, Barbara Szomju, Francesca Peruzzi, Michael D. Wheeler, Michael Kremer, Richard J. Milton, Richard A. Rippe, Fuyumi Isayama, Stephen McKim and Ian N. Hines and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christopher Parsons

23 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Parsons United States 11 179 166 136 70 63 23 466
Zili Liu China 11 146 0.8× 220 1.3× 103 0.8× 181 2.6× 26 0.4× 23 536
Yuhsaku Kanoh Japan 13 94 0.5× 203 1.2× 97 0.7× 67 1.0× 91 1.4× 43 450
Germana Grassi Italy 13 152 0.8× 277 1.7× 100 0.7× 157 2.2× 133 2.1× 28 684
Daisuke Yamaji Japan 13 106 0.6× 289 1.7× 287 2.1× 95 1.4× 109 1.7× 21 648
Yasuyuki Tomiyama Japan 12 243 1.4× 113 0.7× 155 1.1× 45 0.6× 39 0.6× 32 546
R González-Amaro Mexico 9 174 1.0× 108 0.7× 65 0.5× 40 0.6× 188 3.0× 10 570
Guirong Sun China 14 86 0.5× 182 1.1× 131 1.0× 53 0.8× 61 1.0× 32 587
Youzhong Yuan United States 11 66 0.4× 280 1.7× 95 0.7× 39 0.6× 69 1.1× 18 552
Diana Panayotova‐Dimitrova Germany 13 224 1.3× 336 2.0× 59 0.4× 82 1.2× 124 2.0× 21 541

Countries citing papers authored by Christopher Parsons

Since Specialization
Citations

This map shows the geographic impact of Christopher Parsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Parsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Parsons more than expected).

Fields of papers citing papers by Christopher Parsons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Parsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Parsons. The network helps show where Christopher Parsons may publish in the future.

Co-authorship network of co-authors of Christopher Parsons

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Parsons. A scholar is included among the top collaborators of Christopher Parsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Parsons. Christopher Parsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Christopher, et al.. (2022). Venous thrombosis, peripheral aneurysm formation, and fever in a feral pig hunter with Brucellosis. IDCases. 27. e01449–e01449. 3 indexed citations
2.
Huang, Jiapeng, et al.. (2020). Closure of an iatrogenic ventricular septal defect using a hybrid approach and echocardiographic guidance. Annals of Cardiac Anaesthesia. 23(2). 212–212. 4 indexed citations
3.
Parsons, Christopher, et al.. (2019). Diarrheal illness and prosthetic joint infection caused by Campylobacter coli following consumption of undercooked chicken wings. IDCases. 18. e00644–e00644. 2 indexed citations
4.
Parsons, Christopher, et al.. (2019). SomaticNET: Neural network evaluation of somatic mutations in cancer. Annals of Oncology. 30. v584–v584. 1 indexed citations
5.
Uldrick, Thomas S., Priscila Gonçalves, Brinda Emu, et al.. (2019). Phase I study of pembrolizumab in people with HIV and cancer.. Journal of Clinical Oncology. 37(15_suppl). 2500–2500. 3 indexed citations
6.
Parsons, Christopher, et al.. (2018). Successful Treatment of Olecranon Bursitis Caused byTrueperella bernardiae: Importance of Environmental Exposure and Pathogen Identification. SHILAP Revista de lepidopterología. 2018. 1–4. 6 indexed citations
7.
Yin, Qinyan, et al.. (2017). Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells. Virology Journal. 14(1). 121–121. 10 indexed citations
8.
Wyczechowska, Dorota, Hui‐Yi Lin, Adam Lassak, et al.. (2017). A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS. Frontiers in Molecular Neuroscience. 10. 385–385. 16 indexed citations
9.
Seal, Paula, et al.. (2017). Clinical case of the month: a 22-year-old man with AIDS presenting with shortness of breath and an oral lesion.. PubMed. 166(5). 224–30. 1 indexed citations
10.
Uldrick, Thomas S., Martin A. Cheever, Priscila Gonçalves, et al.. (2017). Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer. Journal of Virus Eradication. 3. 55–56. 1 indexed citations
11.
Parsons, Christopher, et al.. (2016). Treatment of HIV-associated Kaposi's sarcoma with aldoxorubicin.. Journal of Clinical Oncology. 34(15_suppl). 11038–11038. 2 indexed citations
12.
Kadri, Ferdous, Marco Pacifici, Anna Wilk, et al.. (2015). HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. Journal of Biological Chemistry. 290(52). 30931–30946. 22 indexed citations
13.
Katz, Paige S., Robert W. Siggins, Arnold H. Zea, et al.. (2015). Chronic alcohol increases CD8+ T-cell immunosenescence in simian immunodeficiency virus-infected rhesus macaques. Alcohol. 49(8). 759–765. 22 indexed citations
14.
Parsons, Christopher, Hillary Dinh, Scott Wieland, et al.. (2015). Treatment of HIV-associated Kaposi's sarcoma with aldoxorubicin.. Journal of Clinical Oncology. 33(15_suppl). e21526–e21526. 3 indexed citations
15.
Marrero, Luis, Dorota Wyczechowska, Anna Wilk, et al.. (2014). Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma. Neoplasia. 16(10). 874–882. 31 indexed citations
16.
Wilk, Anna, Dorota Wyczechowska, Matthew J. Dean, et al.. (2014). Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death. Molecular and Cellular Biology. 35(1). 182–198. 70 indexed citations
17.
Ruiz, Marco, Christopher Parsons, & John T. Cole. (2012). Characterization of HIV-Associated Hodgkin's Lymphoma in HIV-Infected Patients. Journal of the International Association of Physicians in AIDS Care. 11(4). 234–238. 5 indexed citations
18.
19.
Isayama, Fuyumi, Ian N. Hines, Michael Kremer, et al.. (2006). LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(6). G1318–G1328. 106 indexed citations
20.
Parsons, Christopher. (2006). KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. Journal of Clinical Investigation. 116(7). 1963–1973. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zili Liu Breakdown of academic impact, for papers by Yuhsaku Kanoh Breakdown of academic impact, for papers by Germana Grassi Breakdown of academic impact, for papers by Daisuke Yamaji Breakdown of academic impact, for papers by Yasuyuki Tomiyama Breakdown of academic impact, for papers by R González-Amaro Breakdown of academic impact, for papers by Guirong Sun Breakdown of academic impact, for papers by Youzhong Yuan Breakdown of academic impact, for papers by Diana Panayotova‐Dimitrova
Rankless by CCL
2026